(S)-(3-Aminopyrrolidin-1-yl)(phenyl)methanone hydrochloride, 95.0%, 1g

2-(4-Methylnaphthalen-1-yl)acetic acid, 98%, 100mg

1-(trifluoromethyl)cyclopropane-1-carboxamide, 95.0%, 25g

2,4-Dichloro-3,6-dimethylquinoline, 97%, 100mg

tert-butyl rac-(3aR,6aS)-4-oxohexahydrocyclopenta[c]pyrrole-2(1H)-carboxylate, 95.0%, 100mg

N-{9-[(2R,3R,4R,5R)-5-{[bis(4-methoxyphenyl)(phenyl)methoxy]methyl}-3-fluoro-4-hydroxyoxolan-2-yl]-6-oxo-6,9-dihydro-1H-purin-2-yl}-2-methylpropanamide, 97%, 25g

[5-chloro-1-(4-methylbenzenesulfonyl)-1H-pyrrolo[2,3-b]pyridin-3-yl]boronic acid, 95.0%, 1g

1-(4-Fluorophenyl)piperazin-2-one, 95.0%, 250mg

Yttrium ICP standard solution, ROTI®Star, 1000 mg/l Y, density (D) 1.013 g/cm³

ethyl 4-(2,5-dimethylphenyl)-4-oxobutyrate, 97.0%, 1g

1-(3,4-Dimethoxyphenyl)-2-(2-methoxyphenoxy)-propane-1,3-diol, 95.0%, 250mg

6-Chloropyridine-2-carbaldehyde, 95.0%, 1g

Benzyl 3-sulfamoylpiperidine-1-carboxylate, 98%, 250mg